SHINE Technologies vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 54)
SHINE Technologies logo

SHINE Technologies

ChallengerLife Sciences & BioTech

Fusion-Powered Medical Isotope Production

SHINE Technologies uses fusion neutron technology to produce medical isotopes; received a conditional $263M DOE loan in April 2026 to complete the Chrysalis Mo-99 facility in Janesville, WI; facility 75-80% complete.

AI VisibilityBeta
Overall Score
C54
Category Rank
#39 of 198
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
53
Perplexity
55
Gemini
52

About

SHINE Technologies is a Janesville, Wisconsin-based company that is commercializing fusion technology for practical near-term applications — starting with medical isotope production, nuclear waste characterization, and industrial component inspection. Unlike fusion energy companies pursuing electricity generation as their first market, SHINE has built a phased commercialization strategy: its fusion neutron systems produce the radioisotopes used in medical imaging and cancer treatment today, generating commercial revenue while advancing the underlying fusion technology toward energy applications.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

54
Overall Score
74
#39
Category Rank
#11
77
AI Consensus
68
stable
Trend
stable
53
ChatGPT
71
55
Perplexity
68
52
Gemini
80
59
Claude
77
49
Grok
69

Key Details

Category
Fusion-Powered Medical Isotope Production
AI-Enabled Precision Medicine
Tier
Challenger
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.